Evaluation of a Hybrid CNN Model for Automatic Detection of Malignant and Benign Lesions

混合卷积神经网络模型在恶性和良性病变自动检测中的应用评估

阅读:1

Abstract

Background and Objectives: Stratifying thyroid nodules according to malignancy risk is a crucial step in early diagnosis and patient care. Recently, deep learning techniques have emerged as powerful tools for medical diagnostics, particularly with convolutional neural networks (CNNs) applied to medical image classification. This study aimed to develop a new hybrid CNN model for classifying thyroid nodules using the TN5000 ultrasound image dataset. Materials and Methods: The TN5000 dataset includes 5000 ultrasound images, with 3572 malignant and 1428 benign nodules. To address the issue of class imbalance, the researchers applied an R-based anomaly data augmentation method and a GAN-based technique (G-RAN) to generate synthetic benign images, resulting in a balanced dataset for training. The model architecture was built on a pre-trained EfficientNet-B3 backbone, further enhanced with squeeze-and-excitation (SE) blocks and residual refinement modules to improve feature extraction. The task was to classify malignant nodules (labeled 1) and benign nodules (labeled 0). Results: The proposed hybrid CNN achieved strong performance, with an accuracy of 89.73%, sensitivity of 90.01%, precision of 88.23%, and an F1-score of 88.85%. The total training time was 42 min. Conclusions: The findings demonstrate that the proposed hybrid CNN model is a promising tool for thyroid nodule classification on ultrasound images. Its high diagnostic accuracy suggests that it could serve as a reliable decision-support system for clinicians, improving consistency in diagnosis and reducing human error. Future work will focus on clinical validation, explainability of the model's decision-making process, and strategies for integration into routine hospital workflows.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。